Dr. Michiel Strijbos is a Consultant Medical Oncologist at the AZ Klina hospital in Brasschaat, Antwerp. He was trained at Leuven University in Belgium and the Erasmus University in Rotterdam, The Netherlands, where he graduated in 2004. Between 2004 and 2009, he enrolled in a PhD project focusing on tumor vasculature at the Daniel den Hoed Cancer Center in Rotterdam, for which he was awarded a PhD. Dr. Strijbos received his board certification in Medical Oncology in 2014. In his daily practice, Dr. Strijbos focuses on the research and treatment of genitourinary malignancies, as well as sarcoma. He is currently active in several task forces and committees with regards to GU malignancies and is a principal investigator in several clinical trials in this field. He is also a member of the ESMO GU Faculty, EORTC GU group, and serves as an associate editor for the ESMO Open GU section, and co-authored several book chapters related to GU malignancies.